Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock
- 1 May 1986
- journal article
- review article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 12 (3) , 116-126
- https://doi.org/10.1007/bf00254925
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Improvement in Organ Blood Flow by Inhibition of Thromboxane Synthetase During Experimental Endotoxic Shock in the RatJournal of Cardiovascular Pharmacology, 1986
- Protective Effects of trans-13-APT, a Thromboxane Receptor Antagonist, in EndotoxemiaJournal of Cardiovascular Pharmacology, 1985
- Stimulation of prostacyclin synthesis by thromboxane A2-like prostaglandin endoperoxide analogues in cultured vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1984
- Effect of dexamethasone on in vivo prostanoid production in the rabbit.Journal of Clinical Investigation, 1984
- Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.Journal of Clinical Investigation, 1983
- Endogenous prostaglandin F2α in the hyperdynamic state of severe sepsis in manBritish Journal of Surgery, 1983
- PLASMA THROMBOXANE CONCENTRATIONS ARE RAISED IN PATIENTS DYING WITH SEPTIC SHOCKThe Lancet, 1982
- Renal effects of drugs that inhibit prostaglandin synthesisKidney International, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- Elevated Thromboxane Levels in the Rat during Endotoxic ShockJournal of Clinical Investigation, 1980